COVID-19 patients showed a gradual improvement in exercise capacity, a significant decline in SARS-CoV-2 specific IgG and IgM, a mild increase in CD4+ T cells, and diverse changes in several biochemical and haematological biomarkers 6-month after hospital discharge. The gene discussed is CD40LG; the disease is COVID-19.